# A Study of Imaging in Demyelinating Diseases

> **NCT05805839** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 200 (estimated)

## Conditions studied

- Multiple Sclerosis
- Inflammatory Demyelinating Disease

## Interventions

- **DRUG:** C-11 ER176 Radiotracer
- **DRUG:** C11 Pittsburgh Compound B
- **DIAGNOSTIC_TEST:** PET/CT scan
- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT05805839
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-07-10
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05805839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05805839, "A Study of Imaging in Demyelinating Diseases". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05805839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*